Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |